Lovaza and Application site pruritus - a phase IV clinical study of FDA data

Summary:

Application site pruritus is reported as a side effect among people who take Lovaza (omega-3-acid ethyl esters), especially for people who are male, 60+ old, also take Warfarin Sodium, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Application site pruritus when taking Lovaza. It is created by eHealthMe based on reports of 16,646 people who have side effects when taking Lovaza from the FDA, and is updated regularly.

What is Lovaza?

Lovaza has active ingredients of omega-3-acid ethyl esters. It is often used in high blood cholesterol. eHealthMe is studying from 17,340 Lovaza users. Check the latest studies of Lovaza.

What is Application site pruritus?

Application site pruritus (application site severe itching of the skin) is found to be associated with 548 drugs and 910 conditions by eHealthMe. Check the latest studies of Application site pruritus.

On Jul, 14, 2026

16,646 people reported to have side effects when taking Lovaza.
Among them, 14 people (0.08%) have Application site pruritus.

Could Lovaza cause Application site pruritus?

Among these 14 people:

What is the gender of people who have Application site pruritus when taking Lovaza? *

female: 30.77 %
male: 69.23 %

What is the age of people who have Application site pruritus when taking Lovaza? *

What are other drugs people take besides Lovaza? *

What are other side effects people have besides Application site pruritus? *

Application Site Erythema (redness of the skin at application site): 6 people, 42.86%
Application Site Rash: 5 people, 35.71%
Application Site Dermatitis: 3 people, 21.43%
Application Site Pain: 3 people, 21.43%
Weakness: 2 people, 14.29%
Application Site Reaction: 2 people, 14.29%
Fainting (loss of consciousness and postural tone): 2 people, 14.29%
Drug Ineffective: 2 people, 14.29%
Application Site Irritation: 2 people, 14.29%
Application Site Papules (solid elevation of skin with no visible fluid at application site): 2 people, 14.29%

What are the existing conditions these people have? *

Blood Testosterone Decreased: 3 people, 21.43%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 21.43%
Weakness: 2 people, 14.29%
Aortic Disorder: 2 people, 14.29%
Pain: 2 people, 14.29%
Mycosis Fungoides (lymphocytes (a type of white blood cell) become malignant (cancerous) and affect the skin): 1 person, 7.14%
Menopausal Symptoms: 1 person, 7.14%
Memory Loss: 1 person, 7.14%
Inflammatory Bowel Disease: 1 person, 7.14%
Indigestion: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Lovaza and have Application site pruritus?

- Check whether Application site pruritus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lovaza:

Lovaza (17,340 reports)

Browse all side effects of Lovaza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Application site pruritus:

Application site pruritus (548 drugs)

Browse all the conditions that are associated with Application site pruritus:

Application site pruritus (910 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on omega-3-acid ethyl esters (the active ingredients of Lovaza) and Lovaza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.